1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 81-90 of 117 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Anti-phospholipid antibodies in systemic sclerosis: prevalence and clinical correlationsMorrisroe, K.B.; Stevens, W.M.; Byron, J.; Thakkar, V.; Moore, O.; Proudman, S.; Nikpour, M.; Australian Scleroderma Interest Group,; 2012 Annual European Congress of Rheumatology (EULAR) (6 Jun 2012 - 9 Jun 2012 : Berlin, Germany)
2013N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosisThakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; Australian Scleroderma Interest Group,; 2012 Annual European Congress of Rheumatology (EULAR) (6 Jun 2012 - 9 Jun 2012 : Berlin, Germany)
2013An immunochip based interrogation of scleroderma susceptibility variantsCharlesworth, J.; Stankovich, J.; Lewis, P.; Byron, J.; Stevens, W.; Sahhar, J.; Proudman, S.; Roddy, J.; Nash, P.; Tymms, K.; Brown, M.; Zochling, J.; 2012 Annual European Congress of Rheumatology (EULAR) (6 Jun 2012 - 9 Jun 2012 : Berlin, Germany)
2015The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies - a systematic reviewMohamed, H.; Sorich, M.; Kowalski, S.; McKinnon, R.; Proudman, S.; Cleland, L.; Wiese, M.
2013Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?Nikpour, M.; Stevens, W.; Proudman, S.; Buchbinder, R.; Prior, D.; Zochling, J.; Williams, T.; Gabbay, E.; Nandurkar, H.
2011Fatty acid desaturase 2 promoter mutation is not responsible for Δ6-desaturase deficiencyGregory, M.; Lester, S.; Cook-Johnson, R.; Gibson, R.; Proudman, S.; Cleland, L.; James, M.
2013Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung diseaseMoore, O.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Byron, J.; Sahhar, J.; Roddy, J.; Gabbay, E.; Youssef, P.; Nash, P.; Zochling, J.; Proudman, S.; Stevens, W.; Nikpour, M.
2011Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC-MS/MSRakhila, H.; Rozek, T.; Hopkins, A.; Proudman, S.; Cleland, L.; James, M.; Wiese, M.
2017Intracellular CD3⁺ T-lymphocyte teriflunomide concentration is poorly correlated with and has greater variability than unbound plasma teriflunomide concentrationHopkins, A.; Moghaddami, M.; Foster, D.; Proudman, S.; Upton, R.; Wiese, M.
2016The association of low complement with disease activity in systemic sclerosis: a prospective cohort studyEsposito, J.; Brown, Z.; Stevens, W.; Sahhar, J.; Rabusa, C.; Zochling, J.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.

Discover